Purchase Order 75D30122P14061
Award Date
6/10/22
Potential Completion Date
9/30/23
Potential Value
$356K
Federal Agency
CDC Pittsburgh
Awardee
Southern Research Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ13 - General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35205, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2,354,672 delivery order contract to Southern Research - doing business as Southern Research under the master indefinite-delivery indefinite-quantity contract titled Nonclinical Services for Development of Interventional Agents. The delivery order is for NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES to be performed in Birmingham, Alabama over a three year...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Southern Research Institute to conduct COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 cytopathic effect (CPE) assay across two rounds. The $74,000.00 contract has an ultimate completion date of August 28, 2020 and was not set aside for any specific business type. Southern Research Institute is a...
This is a $8,755.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization. The contract has no set-aside designation and was awarded on August 15, 2012, with a completion date of November 30, 2012. Southern Research Institute, doing business as Southern Research, has experience providing drug discovery and development, infectious disease research, and other...
This is a $37,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Southern Research Institute. The contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This non-competitive award was made under simplified acquisition procedures, with the vendor selected due to prior work on the compound testing. The period of performance runs through...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization, under the In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $237,452.00 firm fixed-price task order is for in vitro assessment services related to the development of antimicrobial therapeutics. This task order does not...
The Southern Research Institute was awarded a $271,380 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract by the National Institute of Allergy and Infectious Diseases. Under this contract, Southern Research will provide in vitro assessments of antimicrobial activity to the National Institutes of Health in support of the NIH's research efforts to address infectious diseases. Work will be performed in Birmingham, Alabama over an...
This firm-fixed-price purchase order contract, valued at $47,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Southern Research Institute, a non-profit organization, for COVID-19 compound dose response testing. The contract has no set-aside designation and is part of NCATS' efforts to evaluate potential COVID-19 treatments. Southern Research Institute has a history of providing drug discovery, development, and testing services to...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization, for $544,721.00. The order is for in vitro assessments of antimicrobial activity, and is placed under NIAID's broader In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The award does not have a set-aside designation. Through past prime and...
This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to the Southern Research Institute, a non-profit research organization. The $42,000 contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This work supports NCATS' mission of advancing the translation of medical discoveries into clinical applications. The contract has no...